Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
take every 4 to 6 hours do not take more than 6 doses in 24 hours Age Dose adults and children 12 years and over 1 to 2 capsules children 6 to under 12 years of age 1 capsule children under 6 years of age do not use this product in children under 6 years of age
store at temperature 15° to 30° C (59° to 86°F) do not use if either capsule band or imprinted safety seal under cap is broken or missing protect from moisture
Diphenhydramine Hydrochloride 25 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
| Age | Dose |
| adults and children 12 years and over | 1 to 2 capsules |
| children 6 to under 12 years of age | 1 capsule |
| children under 6 years of age | do not use this product in children under 6 years of age |
colloidal silicon dioxide, croscarmellose sodium, hard gelatin capsules, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline
cellulose, propyl paraben sodium.
Call toll-free 1-877-225-6999
Mfg Lic .No: TN/DRUGS/558/1997
Manufactured for:
Akron Pharma, Inc,
373 RT US 46 W, Building E,
Suite 117, Fairfield, NJ 07004
| Class | Version | Type | Effective |
|---|---|---|---|
| DIPHENHYDRAMINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71399-8028-1 | 2025-01-30 | C162847 | 48780-1 | f386c649-a338-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| 71399-8028-2 | 2025-01-30 | C162847 | 48780-1 | f386c649-a338-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| 71399-8028-1 | 2023-02-28 | C162847 | 48780-1 | f386c649-a338-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| 71399-8028-2 | 2023-02-28 | C162847 | 48780-1 | f386c649-a338-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| 71399-8028-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-a338-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| 71399-8028-2 | 2023-01-30 | C162847 | 48780-1 | f386c649-a338-0266-e053-dadaa90a7c1a | Akron Pharma, Inc. |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71399-8028-1 | Diphenhydramine HCl | 100 in 1 BOTTLE | CAPSULE | 100 | 3 | |
| 71399-8028-2 | Diphenhydramine HCl | 1000 in 1 BOTTLE | CAPSULE | 1000 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71399-8028 | DIPHENHYDRAMINE HCL CAPSULE [AKRON PHARMA INC.] | 3 | Legacy NDC, 2 package rows | 20230302_0617dd75-2e5a-4470-b903-390601c34032.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71399-8028-1 | EA - Each | 71399-8028 | 8f40c734-d0ae-4b7b-b57e-fa2447af6625 | 1 | 2021-03-02 |
| 71399-8028-2 | EA - Each | 71399-8028 | 680ac178-d23a-4ab8-8b14-4417bd5e1823 | 1 | 2021-03-02 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71399-8028 | 71399-8028-1, 71399-8028-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIPHENHYDRAMINE HYDROCHLORIDE | TC2D6JAD40 | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| GELATIN | 2G86QN327L | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| PROPYLPARABEN SODIUM | 625NNB0G9N | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5dfddb99-208f-4c76-8c59-3c13fd5fe52c | 0617dd75-2e5a-4470-b903-390601c34032 | 2023-02-25 | Warnings | 5dfddb99-208f-4c76-8c59-3c13fd5fe52c 0617dd75-2e5a-4470-b903-390601c34032 |
Adverse event summaries are temporarily unavailable. Other product information remains available.